Secondary prevention of heart disease and cardiovascular disease principally involves mitigating risk among individuals considered to be at high risk for serious adverse events that include stroke ...

Secondary prevention refers to using aspirin to reduce the risk of a second or additional heart attack or stroke. It’s different from primary prevention — using aspirin to reduce the risk of a ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to ...

Cardiovascular disease remains a leading cause of death worldwide, and managing it effectively requires more than just ...

Several cardiovascular disease (CV) outcomes trials have evaluated moderate-intensity statin therapy in primary prevention populations with diabetes aged 40-74 years.

A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a ...

Cardiovascular disease (CVD) is responsible for up to 25% of premature deaths in the UK, 80% of which are preventable. We explore the role integrated care systems could play in scaling up the ...

A new editorial in JAMA Cardiology has rekindled discussions about the role of aspirin for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and whether there’s a ...

Wear Red Day, the first Friday of February, draws attention to the prevalence and dangerousness of heart disease in women as part of American Heart Month. Heart disease is the leading cause of ...

Heart disease remains the top global killer. Learn about its impact on health, key risk factors, and approaches to prevention and treatment.

Secondary prevention efforts following hospitalization for coronary heart disease are woefully inadequate and inconsistent across the globe, with striking regional and sex-based disparities, according ...